Literature DB >> 18186964

Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma.

Pier Luigi Zinzani1, Venerino Poletti, Maurizio Zompatori, Monica Tani, Lucia Spaggiari, Sara Tomassetti, Alessandro Broccoli, Enrico Derenzini, Michele Baccarani.   

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphomas were first described by Isaacson and Wright in 1983 in a small series of patients with low-grade B-cell gastrointestinal lymphomas. Although MALT lymphomas occur most frequently in the stomach, they have also been described in various non-gastrointestinal sites, such as the salivary gland, conjunctiva, thyroid, orbit, lung, breast, kidney, skin, liver, uterus, and prostate. The risk of a diagnostic dilemma is reduced by the favorable prognosis of this low-grade lymphoma and its tendency to remain localized to the primary site for a long time. On therapeutic grounds, in contrast to nodal lymphomas, low-grade MALT lymphomas also respond favorably to local treatments, such as surgery and/or local radiation therapy. The outcome and prognosis of low-grade MALT lymphomas are more favorable than those for other extranodal lymphomas. The purpose of this review is to point out the state of the art regarding bronchus-associated lymphoid tissues lymphomas in terms of etiology, pathogenesis, clinics, and therapeutics, including our single-center experience of 23 cases.

Entities:  

Mesh:

Year:  2007        PMID: 18186964     DOI: 10.3816/clm.2007.n.042

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma        ISSN: 1557-9190


  7 in total

1.  Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.

Authors:  Myeong Seok Koh; Won Seog Kim; Seok Jin Kim; Sung Yong Oh; Dok Hyun Yoon; Soon Il Lee; Junshik Hong; Moo Kon Song; Ho-Jin Shin; Jung Hye Kwon; Hyo Jung Kim; Yong Rok Do; Cheolwon Suh; Hyo Jin Kim
Journal:  Int J Hematol       Date:  2015-07-26       Impact factor: 2.490

2.  Tracheal stenting for primary tracheal mucosa-associated lymphoid tissue lymphoma.

Authors:  Juanjuan Ding; Zhuochang Chen; Manli Shi
Journal:  Eur J Med Res       Date:  2013-04-02       Impact factor: 2.175

Review 3.  Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.

Authors:  Sung Yong Oh; Cheolwon Suh
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 3.165

4.  Primary pulmonary non-Hodgkin's lymphoma: a retrospective analysis of 29 cases in a Chinese population.

Authors:  Jiajia Huang; Tongyu Lin; Zhi-Ming Li; Ruihua Xu; Huiqiang Huang; Wenqi Jiang
Journal:  Am J Hematol       Date:  2010-07       Impact factor: 10.047

Review 5.  Primary Pulmonary B-Cell Lymphoma: A Review and Update.

Authors:  Francesca Sanguedolce; Magda Zanelli; Maurizio Zizzo; Alessandra Bisagni; Alessandra Soriano; Giorgia Cocco; Andrea Palicelli; Giacomo Santandrea; Cecilia Caprera; Matteo Corsi; Giulia Cerrone; Raffaele Sciaccotta; Giovanni Martino; Linda Ricci; Francesco Sollitto; Domenico Loizzi; Stefano Ascani
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

Review 6.  Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment.

Authors:  Alice Di Rocco; Luigi Petrucci; Giovanni Manfredi Assanto; Maurizio Martelli; Alessandro Pulsoni
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

7.  Clinical manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma: single-center experience with 18 patients.

Authors:  Shasha Zhao; Lin Zhang; Zhenyang Gu; Chengying Zhu; Shu Fang; Nan Yang; Feiyan Wang; Lixun Guan; Lan Luo; Chunji Gao
Journal:  Onco Targets Ther       Date:  2018-01-24       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.